C: Butler Family via RIP

Inquest into death of young footballer delayed due to vaccine manufacturer lack of engagement 

The inquest into the death of a young footballer has been delayed due to lack of engagement from a pharmaceutical company.

Roy Butler (23) from Waterford died five days post Janssen vaccine. The Janssen vaccine is the ‘one shot’ Covid 19 vaccine manufactured by Johnson and Johnson.

The process of preparing an inquest into his death requires specific information from Janssen but this had not been forthcoming.

Janssen confirmed it had received the request for information following a media query.

“We confirm we have received a notification from the Coroner’s office seeking information,” a spokesperson for Janssen said.

The Butler family have not spoken out since Roy’s tragic death in August 2021.

After the pharmaceutical company issued a statement, Roy’s brother Aaron Butler posted on social media about the family’s quest for truth.

“All we want is the truth, that is the least that Roy and his family and friends deserve,” Aaron said in a statement issued on Facebook.

“I have continuously hoped over the past 18 months that I would not have to do this, but when the inquest into my brother’s death is being delayed I am left with no choice,” Aaron Butler said.

Roy Butler felt unwell immediately after receiving the injection at a vaccination centre on August 12 2021.

He complained of headaches, fever, grogginess and pain in his jaw in the days following the procedure.

He tried to continue his regular activities despite not feeling well.

On Sunday August 15, Roy went to work a night shift at the contact lens manufacturing plant Bausch and Lomb.

After he finished work, he drove home and slept before going to the gym.

He was unable to carry out any physical activities at the gym and returned home early.

At home, he complained of feeling extremes of hot and cold and went upstairs to his bedroom where his condition deteriorated rapidly.

The talented young footballer, who had plans to travel to Dubai, began to suffer seizures, vomiting and convulsions.

Paramedics arrived at the family home and Roy was transferred to University Hospital Waterford.

He was later transferred to Cork University Hospital, where he was pronounced dead the following day, August 17.

A post mortem was conducted at CUH. The autopsy report, along with the report requested from the pharmaceutical company, will form part of the information to be considered by the coroner before the inquest takes place.

It is unlikely the inquest will be held, before Coroner Phillip Comyn, until 2023 at the earliest.

The vaccine manufacturer Janssen said it plans to provide the information requested by Cork City Coroner’s office without delay.

“We will cooperate fully with the Coroner’s office and are currently working through the request. We will respond to the Coroner as soon as possible,” the spokesperson said.

The company issued assurances over its product safety.

“There is no greater priority than the safety and well-being of the people we serve, and we carefully review reports of adverse events in individuals receiving our medicines or vaccines. Any report about an individual receiving our COVID-19 vaccine and our assessment of that report is shared with the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA) and other appropriate health authorities,” the company said in a statement.

The Health Service Executive lists a number of side effects for the Janssen Covid 19 vaccine on its website. The webpage was updated in March 2022 and again this month.

The list includes ‘very unusual blood clots’ as a rare but possibly deadly side effect.

‘Very rare side effects’ include ‘very unusual blood clots with low platelets’ and Guillain-Barré syndrome (GBS) that may affect up to 1 in 10,000 people, according to the HSE.

‘Rare’ side effects of the Janssen injection affecting one in 1,000 people include ‘blood clots in the deep veins – such as deep vein thrombosis and pulmonary embolisms,’ according to the HSE.

“Very rarely, one in 300,000 people may develop very unusual blood clots with low platelets. One in 10 of these people may die. This risk of this very rare condition is higher in young people,” the HSE states on its website.

The HSE warns that ‘uncommon side effects’ may affect up to 1 in 100 people.

These include feeling weak or generally unwell, back pain, dizziness, muscle weakness, pain in the limbs, pain in the throat, rash, sneezing, excessive sweating, a tremor, diarrhoea and an unusual feeling in the skin, such as ‘tingling or a crawling feeling.’

The Janssen shot was issued conditional marketing from the European Medicines Agency (EMA.)

“This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required,” according to the EMA.

Conditional marketing requires the manufacturer to provide results from ongoing clinical trials.

“These trials and additional studies, including independent studies of Covid 19 vaccines coordinated by EU authorities, will provide more information on the vaccine’s long-term safety and its benefits.”

Share mdi-share-variant mdi-twitter mdi-facebook mdi-whatsapp mdi-telegram mdi-linkedin mdi-email mdi-printer mdi-chevron-left Prev Next mdi-chevron-right Related
Comments are open

Should Fr Sheehy apologise to Simon Coveney?

View Results

Loading ... Loading ...